Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis. (Record no. 12470860)

MARC details
000 -LEADER
fixed length control field 01552 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514063626.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200304s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0003-3197
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/000331970305400203
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Schweizer, Johannes
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20030425
245 00 - TITLE STATEMENT
Title Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Angiology
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 155-61 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Abciximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Arterial Occlusive Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fibrinolytic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulin Fab Fragments
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pilot Projects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platelet Glycoprotein GPIIb-IIIa Complex
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tirofiban
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tissue Plasminogen Activator
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tyrosine
General subdivision analogs & derivatives
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kirch, Wilhelm
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Koch, Reiner
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Müller, Axel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hellner, Grit
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Forkmann, Lutz
773 0# - HOST ITEM ENTRY
Title Angiology
Related parts vol. 54
-- no. 2
-- p. 155-61
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/000331970305400203">https://doi.org/10.1177/000331970305400203</a>
Public note Available from publisher's website

No items available.